Lab Bioreagents Buffers have been developed through the screening of >2000 compounds with the support of machine learning (AI) and optimized through kinetic and dynamic binding tests.
Lab Bioreagents LowBinding (LB) Buffers are newly developed assay buffers that provides exceptional performance and broad compatibility for Western blot, ELISA, IHC and nucleic acid detection assays. The LB Buffers helps to reduce the non-specific bindings, negative effects of interfering molecules, and cross-reactivities of antibodies and proteins from biomatrix. Therefore, LB Buffers exhibit the low matrix interference and high signal-to-noise, by which the assay sensitivity and specificity have been significantly improved.
LB Buffer III consists of physical treatment and chemical modified BSA and two proprietary components.
LB Buffer IV consists of physical treatment and chemical modified casein, heterophilic blocker and two proprietary components.
LB Buffer V consists of physical treatment and chemical modified BSA, heterophilic blocker and three proprietary components.